Product Description: Cenmox is a patented, high-potency curcuminoid complex formulated with a proprietary phospholipid delivery system for enhanced systemic bioavailability. It is classified as a dietary supplement intended to provide targeted support for inflammatory pathways, oxidative stress, and joint function. The core active component is derived from Curcuma longa rhizome, standardized to a minimum of 95% total curcuminoids, but its clinical relevance is defined by its unique delivery technology, which addresses the well-documented pharmacokinetic limitations of standard curcumin extracts.
